Monitoring tumor-derived cell-free DNA in patients with solid tumors: clinical perspectives and research opportunities.
about
Twenty Years on: What Do We Really Know about Ewing Sarcoma and What Is the Path Forward?Molecular imaging of breast cancer: present and future directionsWhole blood defensin mRNA expression is a predictive biomarker of docetaxel response in castration-resistant prostate cancer.Identification of Circulating Tumor DNA for the Early Detection of Small-cell Lung CancerOrigins, structures, and functions of circulating DNA in oncologyCirculating mutational portrait of cancer: manifestation of aggressive clonal events in both early and late stages.Current challenges for detection of circulating tumor cells and cell-free circulating nucleic acids, and their characterization in non-small cell lung carcinoma patients. What is the best blood substrate for personalized medicine?Sequencing small genomic targets with high efficiency and extreme accuracy.Sox17 promoter methylation in plasma DNA is associated with poor survival and can be used as a prognostic factor in breast cancer.Quantitative analysis of cell-free DNA in ovarian cancer.Ovarian cancer treatment: The end of empiricism?Neutrophil Extracellular Traps Promote the Development and Progression of Liver Metastases after Surgical Stress.Aberrant methylation of PCDH10 and RASSF1A genes in blood samples for non-invasive diagnosis and prognostic assessment of gastric cancerAlu methylation serves as a biomarker for non-invasive diagnosis of gliomaCirculating and tissue biomarkers in early-stage non-small cell lung cancerDiagnostic value of circulating free DNA for the detection of EGFR mutation status in NSCLC: a systematic review and meta-analysisInvestigational therapies targeting the ErbB family in oesophagogastric cancer.Neutrophil extracellular traps in cancer progression.Overcoming tumor heterogeneity in the molecular diagnosis of urological cancers.Biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.Cell-free DNA - Minimally invasive marker of hematological malignancies.Clinical validation of a highly sensitive assay to detect EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma.A headlight on liquid biopsies: a challenging tool for breast cancer management.Liquid Biopsies in Oncology and the Current Regulatory Landscape.Implementation of a Precision Pathology Program Focused on Oncology-Based Prognostic and Predictive Outcomes.Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer.Elevated Cell-Free DNA Measured by a Simple Assay Is Associated With Increased Rate of Colorectal Cancer Relapse.Comprehensive evaluation of methods to isolate, quantify, and characterize circulating cell-free DNA from small volumes of plasma.Cell-free DNA as a prognostic marker in stage I non-small-cell lung cancer patients undergoing stereotactic body radiotherapy.Molecular Landscape and Treatment Options for Patients with Metastatic Colorectal Cancer.Validation of liquid biopsy: plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancer.Circulating tumor DNA is effective for detection of KRAS mutation in colorectal cancer: a meta-analysis.Cell-free DNA in healthy individuals, noncancerous disease and strong prognostic value in colorectal cancer.Detection of somatic mutations in cell-free DNA in plasma and correlation with overall survival in patients with solid tumors.Mutation detection using plasma circulating tumor DNA (ctDNA) in a cohort of asymptomatic adults at increased risk for cancer.
P2860
Q26782649-395918B8-175C-408B-9C13-F8549344DCACQ26999488-B0788EE9-8D14-4D8E-BB60-36809A2D4C62Q27853196-5BB5DDA3-113F-4B4E-A225-67C2446AE0BBQ28390093-3FA51A47-4EC9-4012-A0C3-7F328326B5C9Q30249103-39F23D7E-91BB-4FAE-A0B1-94C8EC992CEFQ33640472-531C0B49-6C71-4EA9-90B2-319833F006A3Q34577740-363EA24A-03DA-4E2D-8C29-C316DBD4B250Q35554760-E52C5EDF-670F-4254-B6C7-F99EB03311ECQ36151111-E5A1CF8E-DD03-43EE-A9EE-C2BEABC4F245Q36334715-DA5B37D3-93BA-47EA-81DB-71FEC2327F34Q36554444-F77D2EAA-939D-4459-883D-72DE9986858DQ36693228-7CE47F2B-8E23-4025-AF26-2546B606482EQ37001109-642E8EBE-2DA9-4A3D-B84D-392152D18881Q37295593-1C4B1920-9296-4439-800A-41F18AA9B337Q37629653-346B42E2-9420-4DD1-A73C-72E3D76731D0Q37743832-E31CB128-88AA-48C5-A5D3-C2B7BA9E7EE1Q38221886-9A9BC6F5-158B-400B-A7B1-9F7CE8C666A8Q38234749-C22E86BE-4257-4D80-8A7B-53AEA41831F1Q38261250-D4EEA072-E875-4D7D-ACB2-56E8D6F55084Q38263354-2ADB8A3D-E3A0-49A4-B423-268890F23EB1Q38686561-D13B1E4B-31C1-49EE-AA01-273D051B1FE3Q38694431-928693E1-BBA6-4E45-A3F7-30306EE97855Q38704258-0BF5D72B-E290-40B2-9067-85FA038ACDCBQ38871132-1ED02066-12FF-479F-A4E8-ED32E4CAD4A4Q39045171-7626A882-F7A5-4B2F-BDAF-59C83A472F29Q40203060-979AA003-7BD0-47D2-969C-2CA541856E02Q40716508-D6E5AAAE-5623-4C34-9C0C-8A96E6F26686Q40784335-8575317C-5794-448F-90BC-A0F77DAEFC2EQ41157591-ADBC3F8C-419B-48B3-81E5-AE2E46B7DABFQ45989066-72BFF54A-2C92-4D5B-BC8E-5FE2F0925319Q48502619-531C5D3A-0860-43DA-84E6-A93B6178027DQ50198030-76FF191C-ECDA-404A-A8F6-997F51CCBBB1Q53053161-775DCB87-90C1-4F83-8685-F6194F41D859Q54919155-6E43D8CF-37E3-4D40-BCD2-D9EAFB25ADCAQ55004197-7C12106F-9A39-427F-8A83-90A6715A37F1
P2860
Monitoring tumor-derived cell-free DNA in patients with solid tumors: clinical perspectives and research opportunities.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Monitoring tumor-derived cell- ...... es and research opportunities.
@en
type
label
Monitoring tumor-derived cell- ...... es and research opportunities.
@en
prefLabel
Monitoring tumor-derived cell- ...... es and research opportunities.
@en
P2093
P1476
Monitoring tumor-derived cell- ...... es and research opportunities.
@en
P2093
Angela Esposito
Aron Goldhirsch
Carmen Criscitiello
Ida Minchella
Luca Fumagalli
Lucia Gelao
Marzia Locatelli
Nicoletta Colombo
P304
P356
10.1016/J.CTRV.2013.10.003
P577
2013-10-23T00:00:00Z